Innate Pharma SA Class AInnate Pharma SA Class AInnate Pharma SA Class A

Innate Pharma SA Class A

No trades
No trades

Fundamentals and stats

EPS and revenue snapshot

In the last semiannual, the company reported −0.30 EUR per share, beating the −0.30 EUR estimate by 0.00%. Revenue for the same period reached ‪4.14 M‬ EUR, despite the estimate of ‪4.90 M‬ EUR. For the next semiannual, analysts expect −0.31 EUR in earnings per share and ‪3.99 M‬ EUR in revenue.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise